147 related articles for article (PubMed ID: 38065892)
1. Immune checkpoint inhibitor induced colitis and arthritis: A case report.
Xie RX; Xue YB; Ci XY; Zhang MJ
Medicine (Baltimore); 2023 Dec; 102(49):e36334. PubMed ID: 38065892
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature.
Li L; Lou A; Yu J
Ann Palliat Med; 2021 Jul; 10(7):8460-8466. PubMed ID: 34044548
[TBL] [Abstract][Full Text] [Related]
3. Immune-Related Colitis Induced by Camrelizumab: A Case Report.
Cheng S; Yang Y; Yu J; Chen W; Li X
J Inflamm Res; 2023; 16():1727-1731. PubMed ID: 37096128
[TBL] [Abstract][Full Text] [Related]
4. Camrelizumab-induced oral lichenoid reaction with subepithelial CD4+ T-cell infiltration.
Wang X; Fu T; Sun W
J Oncol Pharm Pract; 2024 Jan; 30(1):228-234. PubMed ID: 37817675
[TBL] [Abstract][Full Text] [Related]
5. COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
Holmstroem RB; Nielsen OH; Jacobsen S; Riis LB; Theile S; Bjerrum JT; Vilmann P; Johansen JS; Boisen MK; Eefsen RHL; Marie Svane I; Nielsen DL; Chen IM
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096534
[TBL] [Abstract][Full Text] [Related]
6. Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
Luo H; Lu J; Bai Y; Mao T; Wang J; Fan Q; Zhang Y; Zhao K; Chen Z; Gao S; Li J; Fu Z; Gu K; Liu Z; Wu L; Zhang X; Feng J; Niu Z; Ba Y; Zhang H; Liu Y; Zhang L; Min X; Huang J; Cheng Y; Wang D; Shen Y; Yang Q; Zou J; Xu RH;
JAMA; 2021 Sep; 326(10):916-925. PubMed ID: 34519801
[TBL] [Abstract][Full Text] [Related]
7. Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors.
de Andrea CE; Perez-Gracia JL; Castanon E; Ponz-Sarvise M; Echeveste JI; Melero I; Sanmamed MF; Rodriguez-Ruiz ME
Oncoimmunology; 2020 May; 9(1):1760676. PubMed ID: 32934876
[TBL] [Abstract][Full Text] [Related]
8. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis.
Enwerem NY; Yen EF
Curr Opin Gastroenterol; 2024 Jan; 40(1):50-59. PubMed ID: 37874119
[TBL] [Abstract][Full Text] [Related]
9. Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature.
Liu K; Bao JF; Wang T; Yang H; Xu BP
World J Clin Cases; 2022 Jun; 10(18):6198-6204. PubMed ID: 35949858
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report.
Soma K; Nishida T; Osugi N; Morimura O; Adachi S; Fujii Y; Sugimoto A; Mukai K; Nakamatsu D; Matsumoto K; Yamamoto M
Clin J Gastroenterol; 2022 Feb; 15(1):128-133. PubMed ID: 34716545
[TBL] [Abstract][Full Text] [Related]
11. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
12. RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma.
Yu R; Wang W; Li T; Li J; Zhao K; Wang W; Liang L; Wu H; Ai T; Huang W; Li L; Yu W; Wei C; Wang Y; Shen W; Xiao Z
Future Oncol; 2021 Nov; 17(31):4081-4089. PubMed ID: 34269067
[TBL] [Abstract][Full Text] [Related]
13. Refractory solitary cervical lymph node metastasis after esophageal squamous cell carcinoma surgery and its successful treatment with immune checkpoint inhibitor: A case report and literature review.
Song W; Wang H; Tian Y; Liu S; Chen X; Cui J; Zhao Y
Medicine (Baltimore); 2020 Mar; 99(10):e19440. PubMed ID: 32150096
[TBL] [Abstract][Full Text] [Related]
14. Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis.
Alexander JL; Ibraheim H; Richards C; Shum B; Pavlidis P; Hunter N; Teare JP; Wotherspoon A; Furness A; Turajlic S; Pickering L; Larkin J; Speight A; Papa S; Powell N
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113896
[TBL] [Abstract][Full Text] [Related]
15. A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis.
Naito T; Nosaka T; Takahashi K; Ofuji K; Matsuda H; Ohtani M; Hiramatsu K; Imamura Y; Ishizuka T; Nakamoto Y
Clin J Gastroenterol; 2021 Oct; 14(5):1431-1436. PubMed ID: 34106395
[TBL] [Abstract][Full Text] [Related]
16. Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports.
Zhang Z; Zheng CQ
World J Clin Cases; 2022 Oct; 10(29):10550-10558. PubMed ID: 36312501
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review.
Nakane T; Mitsuyama K; Yamauchi R; Kakuma T; Torimura T
Kurume Med J; 2023 Jul; 68(2):43-52. PubMed ID: 37100606
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
[TBL] [Abstract][Full Text] [Related]
19. Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.
Sleiman J; Wei W; Shah R; Faisal MS; Philpott J; Funchain P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158318
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary treatment of a patient with severe immune checkpoint inhibitor-induced colitis: A case report.
Lu L; Sha L; Feng Y; Yan L
World J Clin Cases; 2022 Dec; 10(35):13108-13114. PubMed ID: 36569020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
